flagship ventures fund  lp  sec form  insider trading screener  openinsider openinsider latest latest cluster buys latest insider trading all filings latest insider purchases latest insider purchases k latest officer purchases k latest ceocfo purchases k latest insider sales latest insider sales k latest officer sales k latest ceocfo sales k top top officer purchases today top officer purchases past week top officer purchases past month top insider purchases today top insider purchases past week top insider purchases past month top insider sales today top insider sales past week top insider sales past month by symbol officer purchases k today officer purchases k past week officer purchases k past month officer sales k today officer sales k past week officer sales k past month officer sales k today no optex officer sales k past week no optex officer sales k past month no optex insider purchases of penny stocks past month insider sales of penny stocks past month charts contact flagship ventures fund  lp  sec form  insider trading screenercik   address one memorial drive th floor cambridge ma  general tickers insider sh price  lqdty m date filing date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    trade date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    filing delay n days ago transaction filing p  purchase s  sale a  grant d  sale to iss g  gift f  tax m  option ex x  option ex c  cnv deriv w  inherited no deriv multiple days traded k own chg  industry all sectors except funds agriculture forestry fish mining construction manufacturing transportation  utilities wholesale trade retail trade financial services closedend funds insider title   officer     cob     ceo     pres     coo     cfo     gc     vp   director    own   other group by filing company company totals num filings num insiders num officers traded k own chg  sort by filing date trade date ticker symbol trade value max results page clear realtime csv options alerts realtime csv options alerts contact us aamended filing dderivative transaction in filing usually option exercise eerror detected in filing mmultiple transactions in filing earliest reported transaction date and weighted average transaction price s  salesale of securities on an exchange or to another persons  saleoesale of securities on an exchange or to another person after option exercisef  taxpayment of exercise price or tax liability using portion of securities received from the companyp  purchasepurchase of securities on an exchange or from another person return to top copyright   openinsidercom all rights reserved home  flagship pioneering skip to content flagship is pioneering about us process culture portfolio careers search for close menu serious health and sustainability needs challenge societies worldwide incremental innovations by incumbents and conventional startups will not meet these challenges pioneering is flagship’s proven process for originating and developing scientific ventures with unprecedented impact pioneering surmounts boundaries obstacles and limits pioneering abandons familiar territory to embrace the transformative potential of new scientific paradigms pioneering creates new futures pioneering is flagship in the news moncef m slaoui phd joins moderna’s board of directors  moderna provides update on mrna rare disease rd strategy  quanterix boosts investments in its accelerator lab to support rapid growth of simoa technology  more news bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version flagship ventures fund  lp institutional portfolio  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  institutional portfolio flagship ventures fund  lp  cambridge parkway th floor cambridge massachusetts    no holdings for this institution latest news headlines us stockssp  dented by earnings dow hits record high pm et   reuters first business declares quarterly cash dividend pm et   globenewswire columnsuperstar firm vogue heads for fire of overvaluation or ice of regulation james saft pm et   reuters us stocks snapshotweak earnings tobacco shares drag sp  lower pm et   reuters avista requests natural gas rate decrease for oregon customers in annual cost adjustment filings pm et   globenewswire view all latest headlines closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft flagship ventures closes  million for its fifth fund flagship ventures closes  million for its fifth fund upsized fund for cambridge venture firm focused on healthcare and sustainability mar    et from flagship ventures cambridge mass march   prnewswire  flagship ventures a leading venture capital and venture creation firm focused on innovations in healthcare and sustainability announced it has raised  million for flagship ventures fund v its largest fund since its founding in  the new investment brings flagships aggregate funds under management to  billion fund v will continue flagships strategy of venture creation through venturelabs™ flagships innovation foundry and earlystage venture investing in therapeutics health technologies and sustainability  specifically in the energy water and agriculturenutrition sectors we closed this fund with nearly twice the amount of capital we had initially sought and in record time said dr noubar afeyan senior managing partner and chief executive officer of flagship ventures the strong interest from new and existing limited partners is a meaningful endorsement of our unique approach flagship is unique in originating and launching its own startups through venturelabs where it discovers and develops disruptive ideas as a foundation for firstinclass companies flagship ventures also funds companies based on breakthrough science and technology originating outside the firm flagships goal is to realize returns from entrepreneurial innovation by building companies based on cuttingedge technology with the potential to solve significant global problems dr afeyan added with this fund we will accelerate our process of creating companies through venturelabs and we anticipate expanding our team and launching as many as five new companies a year going forward flagships previous fund fund iv totaled  million and was raised in  in the past  months flagship has had eight successful initial public offerings including receptos rcpt agios pharmaceuticals agio tetraphase pharmaceuticals ttph and acceleron pharma xlrn in addition a number of gamechanging companies have emerged from venturelabs such as moderna therapeutics which is pioneering messenger rna therapeutics™ and seres health which is developing microbiome therapeutics our strong track record of recent exits underscores our approach to identifying and growing companies that have the ability to bring innovative therapeutics and technologies to market said dr afeyan our business model has proven resilient to changing market conditions and continues to deliver superior returns to our limited partners as part of launching the new fund flagship announced that douglas cole md has been promoted to managing partner and david berry md phd has been promoted to general partner dr cole has led investments in agios pharmaceuticals combinatorx zlcs concert pharmaceuticals cnce editas medicine receptos quanterix syros pharmaceuticals and tetraphase pharmaceuticals dr berry has led several investments and is a cofounder of portfolio companies joule unlimited eleven biotherapeutics ebio seres health and pronutria biosciences doug and david have made significant contributions to flagship and we are pleased to promote them within our organization said dr afeyan their technical organizational and business insights have created substantial value for our investors about flagship ventures the mission of flagship ventures is to realize entrepreneurial innovation the firm operates with a unique business model venturelabs™ our innovation foundry discovers new technologies and launches transformative companies while our venture capital unit funds innovative earlystage companies with the potential of disrupting existing markets founded in  flagship ventures has launched  companies while investing in another  the firm which manages funds totaling  billion is active in three principal business sectors therapeutics health technologies and sustainability for more information visit wwwflagshipventurescom contacts jeffrey krasner flagship ventures w c for flagship venturesemily rossi ruder finn  w  c source flagship ventures related links httpwwwflagshipventurescom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more may    et preview flagship ventures forms strategic innovation partnerships with astrazeneca nestle health science and bayer cropscience aug    et preview flagship ventures appoints agricultural industry leader robert berendes as venture partner my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  flagship ventures fund  lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors flagship ventures fund  lp check out list of companies and businesses related to flagship ventures fund  lp find out flagship ventures fund  lp address and contact details view other people related to flagship ventures fund  lp  coworkers colleagues companions etc address  memorial drive th floor cambridge  ma companies related to flagship ventures fund  lp cikcompany namepositioncompany addresstetraphase pharmaceuticals inc arsenal street suite  watertown bg medicine inc winter street suite  waltham selecta biosciences inc owner  arsenal way watertown eleven biotherapeutics inc owner  first street suite  cambridge seres therapeutics inc sidney street cambridge  flagship ventures fund  lp on the web persons related to flagship ventures fund  lp  tetraphase pharmaceuticals incnamepositioncitynoubar afeyancambridgethomas r baruchsan franciscothomas r baruchsan franciscofrederick r blumebostongaren g bohlindirector garen g bohlindirector watertownjeffrey chodakewitzdirector watertowncmea ventures vi gmbh  co kgsan franciscocmea ventures vi gmbh  co kgsan franciscocmea ventures vi lp owner san franciscocmea ventures vi lp owner san franciscocmea ventures vi management lpsan franciscocmea ventures vi management lpsan franciscodouglas g coledirector cambridgedavid j colliersan franciscodavid j colliersan franciscolubner davidwatertowncole douglaswatertownjacques dumaschief scientificofficer cambridgejuan enriquezbostongordon ericwatertownexcel medical fund lp owner bostonexcel medical ventures llcbostonflagship ventures  general partner llccambridgeflagship ventures fund  l p owner cambridgeflagship ventures general partner llccambridgefmr corp bostonfmr llcbostonfmr llc owner bostonjohn gordon freunddirector palo altojohn gordon freunddirector palo altojohn gordon freunddirector palo altojohn gordon freunddirector palo altogage l patrickdirector gage l patrickdirector watertowngage l patrickdirector watertownl patrick jr giroirdirector dallassteven r phd gullansdirector bostonsteven r phd gullansdirector watertownmacdonald guywatertownkarl d handelsmansan franciscogeraldine henwooddirector cambridgestephen j hoffmanpalo altopatrick taylor hornchief medical officer watertownpaul anthony howardnewtonyasunori kanekopalo altoyasunori kanekopalo altoedwin m kania jrcambridgehandelsman karlwatertownmiller lawrencewatertowndavid charles lubnersvp and cfo watertownguy macdonaldpresident and chief executive cambridgeguy macdonaldpresident and chief executive watertownmediphase dpup llcnewtonmediphase ii annex fund llcnewtonmediphase ii llcnewtonmediphase ii select fund llcnewtonmediphase venture partners dpup limited partnershipnewtonmediphase venture partners ii annex fund limited partnershipnewtonmediphase venture partners ii lp owner newtonmediphase venture partners ii select fund limited partnershipnewtonlawrence g millernewtonandrew myerswatertownenrico petrillobostonweisskoff robertwatertownmagnus ronnwatertownskyline venture management iv llcpalo altoskyline venture management iv llcpalo altoskyline venture partners qualified purchaser fund iv l p owner palo altoskyline venture partners qualified purchaser fund iv l p owner palo altofaysal a sohailsan franciscofaysal a sohailsan franciscomaria d stahlsvp and general counsel cambridgegullans stevewatertownjoyce a sutcliffesenior vice president biology watertownjohn craig thompsonchief operating officer san diegojohn craig thompsonchief operating officer watertownjoaquim trias owner millbraejames f watsonsan franciscojames f watsonsan franciscochristopher wattsvp finance watertownleland websterwatertownnancy wysenskidirector chatsworthnancy wysenskidirector watertownxiaoyi xiao owner watertownpersons related to flagship ventures fund  lp  bg medicine incnamepositioncitycharles h abdalian jrevp  chief financial officer walthamaram s adouriansvp  chief scientific officer walthamaram s adouriansvp  chief scientific officer walthamnoubar afeyandirector lexingtonnoubar afeyandirector cambridgeagtc advisors fund lpcambridgeagtc partners lp owner cambridgeapplied genomic technology capital fund lpcambridgeadourian aramwalthamharrison m bains jrdirector walthamharrison m bains jrdirector walthamstephane banceldirector walthamstephane banceldirector walthameric bouvierpresident ceo walthamgraaf edwin dewalthamgraaf edwin deutrechtwilliam denselgeneral manager cardioscore walthamflagship ventures  general partner llccambridgeflagship ventures management inccambridgeagribusiness management bv gildewalthamagribusiness management bv gildeutrechtgilde europe food  agribusiness fund bvwalthamgilde europe food  agribusiness fund bvutrechtgilde europe food  agribusiness partners ii cvwalthamgilde europe food  agribusiness partners ii cvutrechthealthcare holding bv gildewalthamhealthcare holding bv gildeutrechtneal gordonsvp biomarker discovery walthamstephen p hallevp  chief financial officer burlingtonstephen p hallevp  chief financial officer walthamtimothy jr harrisdirector walthamtimothy jr harrisdirector walthambains harrisonwalthambains harrisonwalthamwilcox harrycambridgeedwin m kania jrcambridgeedwin m kania jr owner cambridgejeffrey r luberdirector marlboroughrogers michaelwalthamstephen r millerchief commercial officer walthampieter muntendamevp chief medical officer walthamnewcogen elan llccambridgenewcogen equity investors llccambridgenewcogen group inccambridgenewcogen group llccambridgenewcogen long reign holding llccambridgenewcogen pe llccambridgeafeyan noubarcambridgeafeyan noubarcambridgejames f o oconnordirector bostonstelios papadopoulosdirector stelios papadopoulosdirector walthamstelios papadopoulosdirector walthamsohmer paulwalthammarc olivier perretwalthammarc olivier perretutrechtmuntendam pieterwalthamvan der meer pieterthe netherlandsbrian s posnerdirector walthambrian s posnerdirector walthamanastasia radersvp executive operations  hr walthamanastasia radersvp executive operations  hr walthammichael w rogersevp cfo and treasurer walthamhaygood paterson seawell sratlantawayne k shepherdvp sales and marketing walthampaul r sohmerpresident  ceo burlingtonpaul r sohmerpresident  ceo walthampaul r sohmerpresident  ceo walthamst newcogen llccambridgepapadopoulos steliosgreat neckpapadopoulos stelioswalthambancel stephanewalthamhall stephenwalthamharris timothywalthamharris timothywalthamder meer pieter vandirector walthamder meer pieter van owner utrechtharry w wilcoxdirector marlboroughpersons related to flagship ventures fund  lp  selecta biosciences incnamepositioncitydavid abrahamgc and corporate secretary watertownnoubar afeyanlexingtonnashat amirwatertownnashat amirwatertownnashat amirwatertownsallin aymericwatertownsallin aymericwatertownsallin aymericwatertowntimothy c barabedirector woburngordon carlwatertowngordon carlwatertowngordon carlwatertownwerner cautreelspresident and ceo woburndouglas colewatertownabraham davidwatertownabraham davidwatertownsiewers davidwatertownsiewers davidwatertownsiewers davidwatertowncole douglaswatertownsands earlwatertownsands earlwatertownkania jr edwinwatertownkania jr edwinwatertownomid farokhzaddirector cambridgeflagship ventures  general partner llccambridgesiber georgewatertownsiber georgewatertowncarl l gordondirector new yorkpeter barton huttdirector irvinesamuel d isalylloyd p johnstoncoo  senior vp rd watertownedwin m kania jrdirector cambridgepeter kellerchief business officer watertowntakashi kei kishimotochief scientific officer watertownrobert langerleukon investments lpchestnut hillshaydullina leysanwatertownjohnston lloydwatertownjohnston lloydwatertownlimited partnership nanodimensiongrand caymannanodimension management ltd owner grand caymanamir nashatdirector san diegofarokhzad omidwatertownfarokhzad omidwatertownfarokhzad omidwatertownorbimed advisors llcdirector orbimed capital gp iii llcnew yorkosage partners llcbala cynwydosage university gp ii lpbala cynwydosage university partners ii lp owner bala cynwydzenner patrickwatertownhutt peterwatertownhutt peterwatertownhutt peterwatertownkeller peterwatertownkeller peterwatertownpolaris venture management co v llc owner walthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners v lpwalthambratzler robertwatertownlanger robertwatertownlanger robertwatertownlanger jr robertwatertownrusnano owner moscowaymeric sallindirector watertownearl sandschief medical officer watertownselecta rkfn ltdmoscowleysan shaydullinawatertowndavid siewerscfo and treasurer watertowntimothy a springerdirector chestnut hillkishimoto takashiwatertownkishimoto takashiwatertowntas partners llcdirector chestnut hillbarabe timothywatertownspringer timothywatertownandrian ulrich vonwatertowncapital ibf netherlands bv vtb owner moscowcautreels wernerwatertowncautreels wernerwatertowncautreels wernerwatertownudaltsov yuriywatertownudaltsov yuriywatertownpatrick j zennerdirector persons related to flagship ventures fund  lp  eleven biotherapeutics incnamepositioncitycelniker phd abbiecambridgenoubar afeyanlexingtonnoubar afeyancambridgenoubar afeyandirector cambridgedecillis arthurcambridgegertz barrycambridgedavid a berrydirector indianapolisdavid a berrydirector cambridgeboxer asset management incnew providenceboxer capital llc owner del marpfeffer carycambridgepfeffer carycambridgeabbie celnikerdirector cambridgepaul g chaneydirector new yorkpaul g chaneydirector cambridgeclairmark investments ltdcambridgeleslie dandirector cambridgelynch danielcambridgeberry davidcambridgeberry davidcambridgearthur decillischief medical officer cambridgewendy l dixondirector princetonwendy l dixondirector cambridgewendy l dixoncambridgejay s dukerdirector cambridgefurfine ericcambridgeflagship ventures  general partner llccambridgeflagship ventures fund iv general partner llccambridgeflagship ventures fund iv lp owner cambridgeflagship ventures fund ivrx lpcambridgeeric steven furfinechief scientific officer cambridgebarry gertzdirector cambridgeperry gregorycambridgejane hendersondirector watertownjane hendersoncambridgestephen a hurlypresident and ceo cambridgesuper v investment limited partnership jafco owner chiyodaku tokyo super v investment limited partnership jafco owner tokyo japansuper v investment limited partnership jafco owner tokyo japansuper v investment limited partnership jafco owner tokyo japansuper v investment limited partnership jafco owner tokyohenderson janecambridgeduker jaycambridgemccabe johncambridgeedwin m kania jrcambridgeedwin m kania jrcambridgeturbridy karencambridgedrapkin kimcambridgedrapkin kimcambridgedan lesliecambridgemark j levincambridgemark j levindirector cambridgemark j levinbostonjoseph lewisdaniel lynchdirector daniel lynchdirector cambridgelevin markcambridgelevin markcambridgejohn j mccabechief financial officer walthammva investors llcdel marafeyan noubarcambridgeafeyan noubarcambridgechaney paulcambridgegregory d perrychief financial and business cambridgegregory d perrycambridgecary pfefferdirector cambridgecary pfefferdirector cambridgekevin p starrbostonkevin p starrbostonhurly stephencambridgerobert i tepperbostonrobert i tepperbostonthird rock ventures gp lpbostonthird rock ventures gp lpbostonthird rock ventures lpbostonthird rock ventures lp owner bostontrv gp llcbostontrv gp llcbostonkaren l tubridychief development officer cambridgedixon wendycambridgepersons related to flagship ventures fund  lp  seres therapeutics incnamepositioncitynoubar afeyandirector lexingtonjohn g auninschief technology officer  evp cambridgedennis a ausiellodirector new yorkgregory behardirector cambridgewerner cautreelsdirector woburndavid n cookchief scientific officer  evp concordberry davidcambridgeberry davidcambridgecook davidcambrdigewillard h deredirector thousand oaksthomas desrosierchief legal officer and evp cambridgeshaff ericcambridgeflagship venturelabs iv llccambridgeflagship ventures  general partner llccambridgeflagship ventures fund iv general partner llccambridgeflagship ventures fund iv lpcambridgeflagship ventures fund ivrx lpcambridgekurt gravesdirector cambridgebehar gregcambridgewael hashadevp  chief commercial officer cambridgepeter barton huttdirector irvineaunins johncambridgeedwin m kania jrcambridgerichard n kenderdirector whitehouse stationlorence h kimdirector cambridgekim lorencecambridgenestle health science us holdings inc owner norwalksa nestlevevey switzerlandnimco us incnorwalkafeyan noubarcambridgeafeyan noubarcambridgehutt petercambridgehutt petercambridgeroger pomerantzpresident and ceo chalfontkender richardcambridgepomerantz rogercambridgepomerantz rogercambridgeeric d shaffcfo and evp cambridgemichele trucksischief medical officer and evp cambridgecautreels wernercambridgecautreels wernercambridge potentially same personnamecitycountryflagship ventures fund  lpsan diegocaflagship ventures fund  lpcambridgemaflagship ventures fund  lpcambridgema form sc da eleven biotherapeutics filed by flagship ventures fund  lp research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form sc da eleven biotherapeutics filed by flagship ventures fund  lp by k wizard—  am et  httparchivefastedgarcomadzcrazkixsluezz filed on april   more ebio news ebio has no more news copyright – fmr llc  all rights reserved  terms of use privacy security site map  ebio stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsebio eleven biotherapeutics inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all todays research report coverage on biotech stocks  eleven biotherapeutics egalet aevi genomic medicine and insys therapeutics pr newswire –  am et  new york july   if you want a stock review on ebio eglt gnmx or insy then come over to httpdailystocktrackercomregister and sign up for your free customized report today eleven biotherapeutics to present at  marcum microcap conference business wire –  am et  eleven biotherapeutics inc ebio a latestage clinical oncology company advancing a broad pipeline of novel product candidates based on its targeting protein therapeutics platform today announced that stephen hurly president and chief executive officer will present a company overview at the  marcum microcap conference in new york on friday june   at  am edt briefeleven biotherapeutics to collaborate with astrazeneca national cancer institute reuters –  am et  eleven biotherapeutics inc ebio  eleven biotherapeutics ebio to collaborate with astrazeneca azn and national cancer institute on development of vicinium in combination with durvalumab  eleven biotherapeutics inc ebio says vicinium is currently in a phase  registration trial for treatment of highgrade nmibc eleven biotherapeutics to collaborate with astrazeneca and the national cancer institute on development of viciniumtm in combination with durvalumab for the treatment of nonmuscle invasive bladder cancer business wire –  am et   cooperative research and development agreement to evaluate activity of elevens targeted therapeutic vicinium in combination with the immune checkpoint inhibitor durvalumab  eleven biotherapeutics inc ebio a latestage clinical oncology company advancing a broad pipeline of novel product candidates based on its targeted protein therapeutics platform today announced the signing of a cooperat briefdsmb recommends eleven bios pivotal trial testing vicinium continue as planned reuters –  am et  eleven biotherapeutics inc ebio  eleven biotherapeutics ebio announces data and safety monitoring board recommendation to continue phase  registration trial with vicinium in nonmuscle invasive bladder cancer based on review of safety and efficacy data  eleven biotherapeutics inc ebio says expects to complete patient enrollment in h and to report topline month data in q eleven biotherapeutics announces data and safety monitoring board dsmb recommendation to continue phase  registration trial with vicinium™ in nonmuscle invasive bladder cancer based on review of safety and efficacy data business wire –  am et  phase  trial enrollment exceeds  company expects to complete patient enrollment in h and to report topline month data in q eleven biotherapeutics inc ebio a latestage clinical oncology company advancing a broad pipeline of novel product candidates based on its targeted protein therapeutics platform today announced that its phase  registration trial of vicinium in nonmuscle inv how these biotech stocks are faring  auris medical eleven biotherapeutics inotek pharma and marinus pharma pr newswire –  am et  new york may   biotechnology firms are among the most researchintensive organizations in the world httpstockcallerscomregistration auris medical ears   on wednesday shares in zug switzerland headquartered auris medical holding ag ears recorded a trading volume of  shares eleven biotherapeutics continues expansion of clinical development team with appointment of david brooks md phd to senior vice president clinical development business wire –  am et   dr brooks brings substantial experience in leading oncology clinical development programs  eleven biotherapeutics inc ebio a latestage clinical oncology company advancing a broad pipeline of novel product candidates based on its targeted protein therapeutics platform today announced the appointment of david brooks md phd to senior vice president clinical development briefeleven biotherapeutics q loss per share  reuters –  am et  eleven biotherapeutics inc ebio  eleven biotherapeutics reports first quarter  financial results  q loss per share   q revenue  versus   eleven biotherapeutics inc ebio  expects to have cash to fund research and development programs and operations into early  source text for eikon further company coverage eleven biotherapeutics reports first quarter  financial results business wire –  am et   continued advancing ongoing phase  registration clinical trial of vicinium in nonmuscle invasive bladder cancer   presented preclinical data at aacr suggesting that lead compounds induce antitumor immune response that can potentiate the activity of immunooncology agents   expanded clinical development team to support ongoing and planned trials   management to host conference  page page  todays and upcoming events aug  ebio to announce q earnings before market unconfirmed past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe flagship ventures fund  lp  agios pharma insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsflagship ventures fund  lpagios pharma agioten percent ownerranked  out of  insiders on tipranksflagship ventures fund  lps performanceprofitable transactions out of  profitable transactionsaverage returnaverage return per transactioneach transaction is measured over a  year months month period and compared to no benchmarksp sectorhow are insiders ranked insider holdings  receptos rcpt  agios pharma agio  eleven biotherapeutics ebiomsee the top stocks by insiders  insider rolesreceptos rcpt ten percent owneragios pharma agio ten percent ownereleven biotherapeutics ebio ten percent ownersee the top  corporate insiders  most profitable insider tradestock receptos rcpttransaction type informative buydates may    may  gain see the latest stocks traded by insiders  flagship ventures fund  lps trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateagioagios pharmaten percent owneruninformative selljun  ebioeleven biotherapeuticsten percent ownerinformative buyfeb  rcptreceptosten percent ownerinformative sellnov  see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by flagship ventures fund  lp  current holdings  fintelio flagship ventures fund  lp current holdings from f d investorflagship ventures fund  lp portfolio value  current positions flagship ventures fund  lp has disclosed  total holdings in their latest sec filings most recent portfolio value is calculated to be   usd actual assets under management aum is this value plus cash which is not disclosed flagship ventures fund  lps top holdings are agios pharmaceuticals inc nasdaqagio  seres therapeutics inc nasdaqmcrb  eleven biotherapeutics inc nasdaqebio  and renewable energy group inc nasdaqregi  flagship ventures fund  lps new positions include agios pharmaceuticals inc nasdaqagio  seres therapeutics inc nasdaqmcrb   flagship ventures fund  lps top industries are chemicals and allied products sic   overview sec filings dg predictive value performance f industry all flagship ventures fund  lp holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc da ebio  eleven biotherapeutics inc     ‑‑ sc ga mcrb  seres therapeutics inc       ‑‑ sc ga agio  agios pharmaceuticals inc   this f was filed on  reporting periodformsecurity imputedshare priceprev sharescurrent shareschange percent prev value kcurrent value kchangepercent ‑‑ fhra mcrb  seres therapeutics inc     ‑‑ fhra ebio  eleven biotherapeutics inc         ‑‑ fhra regi  renewable energy group inc         ‑‑ fhra agio  agios pharmaceuticals inc     fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now from the blog how to launch a hedge fund the piotroski score flagship ventures fund  lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active flagship ventures fund  lp • cambridge ma how do i update this listing flagship ventures fund  is based out of cambridge whalewisdom has at least  fs and  dg filings in our database for flagship ventures fund  summary f holdings ind managers dg insider form  download f summary to excel download f summary to excel create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from flagship ventures fund  lp enter your email address below and choose submit your email cancel  top buys name change  top sells name change  f holdings summary no holdings for current quarter  f sector allocation over time fund metrics you are limited to the prior  quarters of f filings subscribe to whalewisdom to view all filing data for flagship ventures fund  lp portfolio performance top  equalweighted holdings last updated on  performance for q  not ready yet performance last  quarters  performance metrics stats are not available for the latest quarter backtester use whalewisdoms backtester tool to test how a hypothetical portfolio would have performed with different investment strategies research one or more filers performance and then optimize their portfolios to match your own investment goals start with one of our predefined groups or create your own view the backtesting whitepaper and the getting started page for additional help take a tour save changes to tracked backtest saving generate report at least one fund must be selected before running a backtest  ending sector allocation quarter to view current combined fdg q  f filings refresh advanced export download csv download excel xlsx download tsv click to see additional filters security types shares calls puts principal changes in holdings new position added to position reduced position closed out position no change ranking is in the top minimum  of shares stock ticker is etf yesno refresh edit columns shares are split adjusted × report an error your name optional your email optional error to report or any other commentsrequired cancel click here to report any possible errors with this listing f filings available   fhra subscription required   fhr subscription required × csv export module this will schedule a job to export all requested f holdings data for this filer when completed an email will be sent to the email address you specify containing a link to download the zip file of the csv files you requested output type output all f holdings into a single csv file output all f holdings into separate csv files per quarter columns to include filer name stock name stock ticker quarter date type of security current shares held current market value previous shares held previous market value current  of portfolio previous  of portfolio current rank previous rank change in shares type of change sector f quarters to include  email address to send data to cancel schedule export this lets you look at individual sub managers or subsidiaries within the f filing quarter  manager optionally compare to quarter   manager  number of shares is not splitadjusted schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free